|
|
||||||||
Ann Thorac Surg 1999;68:1321-1325
© 1999 The Society of Thoracic Surgeons
a Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA
b Optima Health: Catholic Medical Center, Manchester, New Hampshire, USA
c Eastern Maine Medical Center, Bangor, Maine, USA
d Beth Israel-Deaconess Medical Center, Boston, Massachusetts, USA
e Fletcher-Allen Health Care, Burlington, Vermont, USA
f Maine Medical Center, Portland, Maine, USA
Address reprint requests to Dr Munoz, VA Outcomes Group (111B), Department of Veterans Affairs Hospital, White River Junction, VT 05009
e-mail: john.j.munoz{at}hitchcock.org
Background. While mortality rates associated with coronary artery bypass grafting (CABG) have been declining, it is unknown whether similar improvements in the rates of morbidity have been occurring. This study examines trends in reexploration rates for hemorrhage, one of the serious complications of CABG surgery. It also explores changes in patient characteristics and several surgeon practice patterns potentially related to bleeding risks that may explain variations in these rates.
Methods. We performed a regional observational study of all of the 12,555 consecutive patients undergoing isolated CABG surgery in northern New England between 1992 and 1997. The rates of reexploration and patient characteristics were examined between two time intervals: period I (January 1, 1992 to June 1, 1994) and period II (June 1, 1995 to March 31, 1997). All of the regions 23 practicing surgeons responsible for these patients were surveyed to assess changes in practice patterns potentially related to bleeding risks.
Results. The adjusted rates of reexploration for bleeding declined 46% between periods I and II (3.6% versus 2.0%, p < 0.001). All of the five cardiac centers in northern New England showed similar trends with adjusted risk reductions ranging from 32% to 48% between the two time periods. This decline occurred despite the patients in period II having higher percentages of risk factors for reexploration for bleeding compared to patients in period I. From the surgeon survey, the number of surgeons using antifibrinolytics markedly increased from period I to period II. More surgeons were also using preoperative aspirin and heparin up until the time of surgery in period II.
Conclusions. Similar to the rates of mortality, the rates of reexploration for bleeding following CABG surgery are substantially declining. This decrease in the reexploration rates occurred despite higher patient risks.
This article has been cited by other articles:
![]() |
S. Yavuz, C. Eris, and T. Turk Re-exploration for excessive bleeding after coronary artery bypass surgery: how early is better? Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 819 - 820. [Full Text] [PDF] |
||||
![]() |
R. Wolfe, S. Bolsin, M. Colson, and P. Stow Monitoring the rate of re-exploration for excessive bleeding after cardiac surgery in adults Qual. Saf. Health Care, June 1, 2007; 16(3): 192 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ponce, K. Armstrong, K. Andrews, J. Hensler, K. Waggie, J. Heffernan, T. Reynolds, and M. Rogge Safety of Recombinant Human Factor XIII in a Cynomolgus Monkey Model of Extracorporeal Blood Circulation Toxicol Pathol, October 1, 2005; 33(6): 702 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dial, E. Delabays, M. Albert, A. Gonzalez, J. Camarda, A. Law, and D. Menzies Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 654 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Morawski, M. Sanak, M. Cisowski, M. Szczeklik, W. Szczeklik, J. Dropinski, T. Waclawczyk, R. Ulczok, and A. Bochenek Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 791 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Bybee, B. D. Powell, U. Valeti, A. G. Rosales, S. L. Kopecky, C. Mullany, and R. S. Wright Preoperative Aspirin Therapy Is Associated With Improved Postoperative Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Circulation, August 30, 2005; 112(9_suppl): I-286 - I-292. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Cannon, S. R. Mehta, and S. F. Aranki Balancing the Benefit and Risk of Oral Antiplatelet Agents in Coronary Artery Bypass Surgery Ann. Thorac. Surg., August 1, 2005; 80(2): 768 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Karthik, A. D. Grayson, E. E. McCarron, D. M. Pullan, and M. J. Desmond Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay Ann. Thorac. Surg., August 1, 2004; 78(2): 527 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Harrington, J. P. Lilley, S. J. Rooney, and R. S. Bonser Nonneurologic morbidity and profound hypothermia in aortic surgery Ann. Thorac. Surg., August 1, 2004; 78(2): 596 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Andreasen and C. Nielsen Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 311 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Englberger, B. Faeh, P. A. Berdat, F. Eberli, B. Meier, and T. Carrel Impact of clopidogrel in coronary artery bypass grafting Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 96 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hayat and W. C. Dihmis Preoperative and immediate postoperative aspirin also reduces morbidity Ann. Thorac. Surg., November 1, 2001; 72(5): 1797 - 1797. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |